Parkinson’s Disease and Medical Treatment Options Essay

Parkinson disease (PD) is one of the most common neurologic disorders. and it affects approximately 1% of individuals older than 60 years old. Parkinson’s disease is a condition that progresses slowly by treatment. In addition, loss of pigmented dopaminergic neurons of the substantianigra pars compacta and the presence of Lewy bodies and Lewyneurites are the two major neuropathologic findings in Parkinson disease (Hauser, 2016).

J.N., a 65-year-old Caucasian female with a history of anxiety and depression, presents for diagnostic testing at Saint Mary Medical Center in Hobart, Indiana to confirm or deny a diagnosis of Parkinson’s Disease, after presenting with recent onset of upper extremity tremor affecting both sides and facial masking. Patient history also includes bradykinesia, restlessness, fatigue, muscle weakness, and poor balance and coordination, all of which are common in a diagnosis of Parkinson’s Disease. J.N. was referred to the Neurology Department of Saint Mary Medical Center after a routine appointment with her Cardiologist, who noted the recent onset of additional signs and symptoms. J.N. is my mother and my inspiration for this assignment.

Parkinson’s disease is a common disease facing many older people across the world. It affects the central nervous system and it impairs cognitive processes, motor skills and other functions. This disease mostly affects the older generation and it manifests itself with symptoms which include rigidity, tremor, postural instability, slowness in movement and others. Other symptoms include sleep difficulties, sensory and autonomic dysfunction. Parkinson’s disease has a high prevalence rate among older people with approximately 500,000 people suffering from the disease in the United States. In addition, there are approximately 1 million people who suffer from the disease but they have not been diagnosed yet (Oxtoby et. al.,

Parkinson’s disease is a “neurodegenerative disorder of the basal nuclei due to insufficient secretion of the neurotransmitter dopamine” (Marieb & Hoehn, 2013, p. G-17). The cause of Parkinson’s disease is unknown, but many factors play a role in the development of Parkinson’s disease. One factor that has been found in an individual who has Parkinson’s disease causes over activity of targeted dopamine-deprived basal nuclei. This over activity is caused by the breakdown of neurons that release dopamine in the substantia nigra (Marieb & Hoehn, 2013). Another factor that is present in a person who has Parkinson’s disease, is the presence of lewy bodies in the brain stem ("What is lbd?," 2014). Lewy bodies are unusual

Many may not know Parkinson’s disease is the second most common neurodegenerative disorder in the world. This disease is most seen in the elderly starting at 62 years of age although, younger individuals can still have the disease it isn’t common. Parkinson’s make it difficult for its victims to carry out everyday activities that might have once been easy for them. As the disease progresses it makes it hard for the patient to do things like walk, stand, swallow and speak. A great deal of people don’t realize how helpful therapy can be when dealing with such disease!

Parkinson disease (PD), also referred to as Parkinson’s disease and paralysis agitans, is a progressive neurodegenerative disease that is the third most common neurologic disorder of older adults. It is a debilitating disease affecting motor ability and is characterized by four cardinal symptoms: tremor rigidity, bradykinesia or kinesis (slow movement/no movement), and postural instability. Most people have primary, or idiopathic, disease. A few patients have secondary parkinsonian symptoms from conditions such as brain tumors and certain anti-psychotic drugs.

As a neurodegenerative brain disorder, Parkinson’s disease affects the neurons in the human brain. This disease affects everyone differently. However, there are common symptoms that all patients with Parkinson’s experience. At this time, there is no cure for the disease, but there are several ways to improve the quality of life. Although research is never complete, there is a lot of information on Parkinson’s disease that individuals should know.

Parkinson’s Disease is known as one of the most common progressive and chronic neurodegenerative disorders. It belongs to a group of conditions known as movement disorders. Parkinson disease is a component of hypokinetic disorder because it causes a decreased in bodily movement. It affects people who are usually over the age of 50. It can impair an individual motor as well as non-motor function. Some of the primary symptoms of Parkinson’s disease are characterized by tremors or trembling in hands, legs and arms. In early symptoms the tremor can be unilateral, appearing in one side of body but progression in the disease can cause it to spread to both sides; rigidity or a resistant to movement affects most people with Parkinson’s disease,

Parkinson’s disease (PD) is a progressive disorder of unknown etiology that has no cure. It is characterized by bradykinesia, rest tremor, cogwheel rigidity and postural instability, along with a number of non-motor signs. The neurochemical hallmark of PD is dopamine loss in the nigrostriatal dopamine system (Adler, 2011). In the substantia nigra (SN) of people with PD there is a loss of neuronal cells, demonstrated by the degeneration of brainstem nuclei (Brooks, 1998). This typically shows as Lewy bodies – spherical masses of protein that develop inside nerve cells. However the progression of neuronal loss is quite variable in different PD patients and at different phases of the disease. At present there is no treatment that affects the degeneration, for example by slowing the rate of cell death or by protecting neurons.

Parkinson’s disease is a progressive loss of functioning of the brain that results in stiffness, trembling and loss of fine motor control. This disease mainly affects the neurons in the particular area called the substantia nigra with a total loss of dopamine, the absence of these dopamine-producing cells causes the loss of the brain’s ability to control the body movements progressively ("Parkinson’s disease", 2016). Parkinson’s disease is very common, with about 70000 Australians as well as the average age of diagnosis is 65 years, however, upcoming generations can also be diagnosed with Parkinson’s. It is also not easy to analyze Parkinson’s as there is no laboratory test, but a neurologist can make the diagnosis of this disease ("What is Parkinson 's", 2016). John Magill has a case of Parkinson’s disease before 5 years and after having a fall at home, he was admitted to the hospital and was recognised as having a generalised tremor and decrease in mobility. This essay aims to provide the risk factors, clinical manifestation, medical managements, holistic nursing care plan and discharge plan for John Magill.

Parkinson's is a chronic and progressive movement disorder and it worsens over time. Nearly a million people are living with Parkinson's in the us. There is no known cure but there is medication and surgery which can help manage the symptoms. the cause is unknown.Parkinsons involves the death of neurons in the area of the brain called the Substantia Nigral. Some of these neurons release dopamine a chemical that sends messages to the part of the brain in charge of movement and coordination.As Parkinson's progresses the amount of dopamine decreases leaving the brain unable to control movement normally. The symptoms of Parkinson's are the slowness of thought, Forgetfulness

At present there have been great strides made in the research and therapy of Parkinson’s disease. Some of the therapies which will soon be available include the transplantation of healthy dopamine-producing tissues into the brain and the use of medications to prevent dopamine producing brain cells from becoming damaged or lost. It is the understanding of what is Parkinson’s Disease that can help those who have been diagnosed with

Parkinson’s Disease is a very common disorder these days. Over 10 million people live daily with Parkinson worldwide. Parkinson’s Disease was named after an English surgeon James Parkinson who wrote a detailed description essay called Shaking Palsy in 1817. The average age for Parkinson’s Disease is between 45 to 70 years old but you can also have juvenile or young onset as well. Most common symptoms of Parkinson are tremors, bradykinesia or akinesia, or rigidity or stiffness, and balance disorder. Parkinson’s Disease doesn’t have a cure and the cause is unknown it could be a number of things genetics, environmental triggers, age, or gender. Parkinson’s Disease happens because the dopaminergic neuron dies and

Attempts to cure or slow down the progression of Parkinson’s disease have largely failed; researchers in this paper maintain this is obviously a direct result of the lack of insight into the pathogenesis of the disease. Parkinson’s disease is the product of the deaths of a number of dopaminergic (dopamine-secreting) neurons in the substantia nigra pars compacta region (SNc) of the brain. But what causes these deaths? In the paper “‘Rejuvenation’ protects neurons in mouse models of Parkinson’s disease,” Chen and researchers find that older neurons in the SNc are unusually reliant on calcium channels and that after blocking these channels, the cells are “rejuvenated” and begin acting like their juvenile counterparts; as a

Parkinson disease (PD) is a progressive neurodegenerative disorder characterized mainly by physical and psychological disabilities. This disorder was named after James Parkinson, an English physician who first described it as shaking palsy in 1817 (Goetz, Factr, and Weiner, 2002). Jean- Martin Charcot, who was a French neurologist, then progressed and further refined the description of the disease and identified other clinical features of PD (Goetz, Factr, and Weiner, 2002). PD involves the loss of cells that produce the neurotransmitter dopamine in a part of the brain stem called the substansia nigra, which results in several signs and symptoms (Byrd, Marks, and Starr, 2000). It is manifested clinically by tremor,